Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease

被引:44
|
作者
Orlando, Ambrogio [1 ]
Orlando, Rosalba [1 ]
Ciccia, Francesco [2 ]
Renna, Sara [1 ]
Rizzo, Aroldo [3 ]
Cottone, Mario [1 ]
Macaluso, Fabio Salvatore [1 ]
机构
[1] Villa Sofia Cervello Hosp, Div Internal Med, Palermo, Italy
[2] Univ Palermo, Sect Rheumatol, Di Bi MIS, Palermo, Italy
[3] Villa Sofia Cervello Hosp, Dept Pathol, Palermo, Italy
关键词
MAINTENANCE THERAPY; INDUCTION; GUT;
D O I
10.1136/annrheumdis-2016-211011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
下载
收藏
页数:2
相关论文
共 50 条
  • [41] Clinical outcomes of vedolizumab withdrawal in inflammatory bowel disease for patients in histological remission
    Blad, William
    Whitley, Lisa
    Harrow, Paul
    GUT, 2023, 72 (SUPPL_2) : A87 - A88
  • [42] The Impact of Vedolizumab and Ustekinumab on Articular Extra-Intestinal Manifestations in Inflammatory Bowel Disease Patients: A Real-Life Multicentre Cohort Study
    De Galan, Cara
    Truyens, Marie
    Peeters, Harald
    Gismero, Francisco Mesonero
    Elorza, Ainara
    Torres, Paola
    Vandermeulen, Liv
    Amezaga, Aranzazu Jauregui
    Ferreiro-Iglesias, Rocio
    Holvoet, Tom
    Zabana, Yamile
    Reverter, Laia Peries
    Gonzales, Gerard Bryan
    Geldof, Jeroen
    Varkas, Gaelle
    De Vos, Martine
    Lobaton, Triana
    JOURNAL OF CROHNS & COLITIS, 2022, 16 (11): : 1676 - 1686
  • [43] Benefit of measuring vedolizumab concentrations in inflammatory bowel disease patients in a real-world setting
    Kolehmainen, Sara
    Ylisaukko-Oja, Tero
    Jokelainen, Jari
    Koivusalo, Mirkka
    Jokiranta, T. Sakari
    Sipponen, Taina
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2021, 56 (08) : 906 - 913
  • [44] Effect of vedolizumab and ustekinumab on articular manifestations in patients with inflammatory bowel disease refractory or intolerant to anti-TNF therapy: An observational prospective study
    Britschu, O.
    Meyer, A.
    Gottenberg, J. E.
    Reimund, J. M.
    Caron, B.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S472 - S473
  • [45] Management of patients with inflammatory bowel disease and spondyloarthritis
    Pouillon, Lieven
    Bossuyt, Peter
    Vanderstukken, Joke
    Moulin, David
    Netter, Patrick
    Danese, Silvio
    Jouzeau, Jean-Yves
    Loeuille, Damien
    Peyrin-Biroulet, Laurent
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (12) : 1363 - 1374
  • [46] SAFETY OF VEDOLIZUMAB USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Shivashankar, Raina
    Ladd, Antonio H. Mendoza
    Grace, Rory
    Aberra, Faten
    Lichtenstein, Gary R.
    GASTROENTEROLOGY, 2017, 152 (05) : S585 - S585
  • [47] Vedolizumab Use in Pediatric Patients With Inflammatory Bowel Disease
    Singh, Namita
    Patel, Minesh
    Rabizadeh, Shervin
    Dubinsky, Marla
    GASTROENTEROLOGY, 2015, 148 (04) : S72 - S72
  • [48] Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritis
    Luchetti, Michele Maria
    Benfaremo, Devis
    Bendia, Emanuele
    Bolognini, Laura
    Fava, Giammarco
    Marini, Francesco
    Di Sario, Antonio
    Ciferri, Monia
    Di Nicola, Francesca
    Marconi, Valentina
    Perini, Lucia
    Manfredi, Lucia
    Pomponio, Giovanni
    Mosca, Piergiorgio
    Benedetti, Antonio
    Gabrielli, Armando
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2019, 64 : 76 - 84
  • [49] The role of ustekinumab and vedolizumab in management of extra intestinal manifestations in inflammatory bowel disease
    Katsanos, Konstantinos H.
    Fousekis, Fotios S.
    Armuzzi, Alessandro
    DIGESTIVE AND LIVER DISEASE, 2023, 55 (02) : 149 - 150
  • [50] Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease
    Pavlidis, P.
    Graham, J.
    Gulati, S.
    Dubois, P.
    Heneghan, M.
    Joshi, D.
    Hayee, B.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (10) : 1422 - 1423